Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) Non Operating Income (2017 - 2019)

Updated

Krystal Biotech's Non Operating Income was $542,000 in Q2 2019, up 213.3% from $173,000 a year earlier but down 7.0% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Non Operating Income (2017 - 2019) Analysis & Trends

On a trailing twelve-month basis, Krystal Biotech's Non Operating Income was $1.52 million through Jun 30, 2019; for FY2017, it came in at -$3.15 million.

  • In earlier years, Non Operating Income was -$7,000 in FY2016.
  • Quarterly Non Operating Income has moved between -$3.18 million (Q3 2017) and $583,000 (Q1 2019) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 542,000.00
Mar 31, 2019 583,000.00
Dec 31, 2018 511,000.00
Sep 30, 2018 217,000.00
Jun 30, 2018 173,000.00
Mar 31, 2018 127,000.00
Dec 31, 2017 105,000.00
Sep 30, 2017 -3.18 Mn
Jun 30, 2017 -44,000.00
Mar 31, 2017 -29,000.00
API Access

Krystal Biotech Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRYS&period=max&api_key=YOUR_API_KEY